X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 99 filers reported holding X4 PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,592,702 | -39.8% | 2,378,626 | +7.2% | 0.00% | – |
Q2 2023 | $4,305,991 | +2800.6% | 2,219,583 | +1200.8% | 0.00% | – |
Q1 2023 | $148,451 | -56.2% | 170,633 | -50.0% | 0.00% | – |
Q4 2022 | $338,878 | +260.5% | 341,266 | +523.5% | 0.00% | – |
Q3 2022 | $94,000 | +77.4% | 54,733 | 0.0% | 0.00% | – |
Q2 2022 | $53,000 | -44.8% | 54,733 | 0.0% | 0.00% | – |
Q1 2022 | $96,000 | -13.5% | 54,733 | +12.9% | 0.00% | – |
Q4 2021 | $111,000 | -56.6% | 48,480 | 0.0% | 0.00% | – |
Q3 2021 | $256,000 | -18.7% | 48,480 | 0.0% | 0.00% | – |
Q2 2021 | $315,000 | -86.8% | 48,480 | -82.5% | 0.00% | – |
Q1 2021 | $2,384,000 | -9.6% | 276,840 | -32.5% | 0.00% | – |
Q4 2020 | $2,636,000 | -8.0% | 409,910 | -3.1% | 0.00% | – |
Q3 2020 | $2,864,000 | -26.9% | 423,086 | +0.7% | 0.00% | – |
Q2 2020 | $3,917,000 | +42.4% | 420,286 | +52.9% | 0.00% | – |
Q1 2020 | $2,750,000 | +47.1% | 274,955 | +57.4% | 0.00% | – |
Q4 2019 | $1,869,000 | +3.5% | 174,664 | +23.0% | 0.00% | – |
Q3 2019 | $1,805,000 | +48.7% | 142,007 | +75.5% | 0.00% | – |
Q2 2019 | $1,214,000 | +294.2% | 80,926 | +357.4% | 0.00% | – |
Q1 2019 | $308,000 | – | 17,692 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |